$7.31
3.25% today
NYSE, Apr 01, 06:21 pm CET
ISIN
US34965K1079
Symbol
FTRE

Fortrea Stock price

$7.55
-6.30 45.49% 1M
-12.45 62.25% 6M
-11.10 59.52% YTD
-32.46 81.13% 1Y
-22.55 74.92% 3Y
-22.55 74.92% 5Y
-22.55 74.92% 10Y
NYSE, Closing price Mon, Mar 31 2025
-0.48 5.98%
ISIN
US34965K1079
Symbol
FTRE
Sector
Industry

Key metrics

Market capitalization $681.01m
Enterprise Value $1.76b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 7.42
EV/Sales (TTM) EV/Sales 0.65
P/S ratio (TTM) P/S ratio 0.25
P/B ratio (TTM) P/B ratio 0.50
Revenue growth (TTM) Revenue growth -13.27%
Revenue (TTM) Revenue $2.70b
EBIT (operating result TTM) EBIT $-111.80m
Free Cash Flow (TTM) Free Cash Flow $237.30m
Cash position $118.50m
EPS (TTM) EPS $-3.45
P/E forward negative
P/S forward 0.27
EV/Sales forward 0.71
Short interest 12.55%
Show more

Is Fortrea a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Fortrea Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Fortrea forecast:

2x Buy
15%
10x Hold
77%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Fortrea forecast:

Buy
15%
Hold
77%
Sell
8%

Financial data from Fortrea

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,696 2,696
13% 13%
100%
- Direct Costs 2,248 2,248
16% 16%
83%
449 449
6% 6%
17%
- Selling and Administrative Expenses 475 475
117% 117%
18%
- Research and Development Expense - -
-
-
-27 -27
113% 113%
-1%
- Depreciation and Amortization 85 85
27% 27%
3%
EBIT (Operating Income) EBIT -112 -112
228% 228%
-4%
Net Profit -309 -309
8,985% 8,985%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about Fortrea directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fortrea Stock News

Neutral
GlobeNewsWire
7 days ago
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fortrea Holdings Inc. (NASDAQ:FTRE) and Ibotta, Inc. (NYSE:IBTA). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional infor...
Neutral
Business Wire
12 days ago
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON FORTREA HOLDINGS INC. (FTRE), CLICK HERE TO INQUIRE ABO...
Neutral
Business Wire
12 days ago
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FORTREA HOLDINGS INC. (FTRE), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUIN...
More Fortrea News

Company Profile

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.

Head office United States
CEO Thomas Pike
Employees 15,500
Founded 2023
Website fortrea.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today